Feasibility of Collecting Quality of Life Data in Collaboration With the Stem Cell Therapeutic Outcomes Database

Completed

Conditions studied: Hematopoietic Stem Cell Transplantation

In brief

This is a multi-institution, non-randomized, prospective pilot study to evaluate the feasibility of collecting quality of life (QOL) data on a large cohort of pediatric and adult allogeneic Hematopoietic stem cell transplantation (HCT) recipients.

Key facts

Study ID

NCT01353677

Run by

Center for International Blood and Marrow Transplant Research

People needed

390

Starts

2011-07-01

Expected to finish

2014-10-30

Last updated by the study team

2017-07-25

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult (≥ 18 years), or pediatric (≥ 2 years and < 18 years) allogeneic HCT recipient (related, unrelated, or CBU) at participating pilot study transplant centers.
• Signed informed consent form from adult patient or parent/guardian of pediatric patient.
• Patient must have a valid mailing address within the United States to receive QOL surveys.
• Ability to speak and read English.
• Patients with access to a telephone.

Where it is running

• University of Florida — Gainesville, Florida, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States
• University Hospitals of Cleveland — Cleveland, Ohio, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.